Benjamin Lang

2.1k total citations
62 papers, 1.5k citations indexed

About

Benjamin Lang is a scholar working on Molecular Biology, Immunology and Economics and Econometrics. According to data from OpenAlex, Benjamin Lang has authored 62 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 14 papers in Immunology and 9 papers in Economics and Econometrics. Recurrent topics in Benjamin Lang's work include Heat shock proteins research (20 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers) and Endoplasmic Reticulum Stress and Disease (7 papers). Benjamin Lang is often cited by papers focused on Heat shock proteins research (20 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers) and Endoplasmic Reticulum Stress and Disease (7 papers). Benjamin Lang collaborates with scholars based in United States, Germany and Japan. Benjamin Lang's co-authors include Stuart K. Calderwood, Viktoria Moschetti, Stephan Glund, Paul Reilly, Joachim Stangier, Michael Schmohl, Stephen H. Norris, Steven Ramael, Thomas L. Prince and Joanne van Ryn and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Circulation.

In The Last Decade

Benjamin Lang

60 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin Lang United States 21 535 503 376 270 131 62 1.5k
Dragica Radojković Serbia 20 211 0.4× 455 0.9× 197 0.5× 107 0.4× 71 0.5× 130 1.4k
Yohko Kawai Japan 26 949 1.8× 418 0.8× 687 1.8× 315 1.2× 316 2.4× 67 2.4k
Thomas Girard United States 20 273 0.5× 298 0.6× 159 0.4× 83 0.3× 143 1.1× 44 1.9k
Erica Sparkenbaugh United States 21 122 0.2× 467 0.9× 110 0.3× 293 1.1× 109 0.8× 43 1.5k
Olga Vitseva United States 17 253 0.5× 463 0.9× 126 0.3× 484 1.8× 122 0.9× 30 1.7k
Hans Peter Schwarz Austria 22 120 0.2× 306 0.6× 167 0.4× 422 1.6× 104 0.8× 60 1.9k
Sherry L. Spinelli United States 25 123 0.2× 725 1.4× 44 0.1× 232 0.9× 132 1.0× 49 1.9k
Takayuki Iwaki Japan 18 161 0.3× 202 0.4× 66 0.2× 183 0.7× 92 0.7× 44 1.1k
Eric Villard France 19 1.3k 2.5× 437 0.9× 131 0.3× 42 0.2× 358 2.7× 46 2.0k
Shigeru Shirakawa Japan 28 143 0.3× 654 1.3× 176 0.5× 480 1.8× 204 1.6× 98 2.3k

Countries citing papers authored by Benjamin Lang

Since Specialization
Citations

This map shows the geographic impact of Benjamin Lang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Lang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Lang more than expected).

Fields of papers citing papers by Benjamin Lang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Lang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Lang. The network helps show where Benjamin Lang may publish in the future.

Co-authorship network of co-authors of Benjamin Lang

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Lang. A scholar is included among the top collaborators of Benjamin Lang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Lang. Benjamin Lang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schütz, Helmut, Divan A. Burger, Erik Cobo, et al.. (2024). Group-by-Treatment Interaction Effects in Comparative Bioavailability Studies. The AAPS Journal. 26(3). 50–50.
3.
Lang, Benjamin, et al.. (2023). Fabrication of a Low-Cost, Fiber-Coupled, and Air-Spaced Fabry-Pérot Etalon. Journal of Visualized Experiments. 1 indexed citations
4.
Prince, Thomas L., Benjamin Lang, Yuka Okusha, Takanori Eguchi, & Stuart K. Calderwood. (2022). Cdc37 as a Co-chaperone to Hsp90. Sub-cellular biochemistry. 101. 141–158. 7 indexed citations
5.
Menter, Alan, Stanley Cohen, Jonathan Kay, et al.. (2022). Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial. American Journal of Clinical Dermatology. 23(5). 719–728. 20 indexed citations
6.
Baum, Patrick, Sudha Visvanathan, Sandra Garcet, et al.. (2021). Pustular psoriasis: Molecular pathways and effects of spesolimab in generalized pustular psoriasis. Journal of Allergy and Clinical Immunology. 149(4). 1402–1412. 52 indexed citations
7.
Lang, Benjamin, Thomas L. Prince, Yuka Okusha, Heeyoun Bunch, & Stuart K. Calderwood. (2021). Heat shock proteins in cell signaling and cancer. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1869(3). 119187–119187. 29 indexed citations
8.
Lingvay, Ildiko, Nadine Beetz, Regina Sennewald, et al.. (2020). Triple fixed-dose combination empagliflozin, linagliptin, and metformin for patients with type 2 diabetes. Postgraduate Medicine. 132(4). 337–345. 17 indexed citations
9.
Rigo, Maurício, Thiago J. Borges, Benjamin Lang, et al.. (2020). Host expression system modulates recombinant Hsp70 activity through post‐translational modifications. FEBS Journal. 287(22). 4902–4916. 6 indexed citations
10.
Wolfsegger, Martin J., Helmut Schütz, Richardus Vonk, et al.. (2020). Assessing goodness‐of‐fit for evaluation of dose‐proportionality. Pharmaceutical Statistics. 20(2). 272–281. 3 indexed citations
11.
Ring, Arne, et al.. (2019). Sample size determination in bioequivalence studies using statistical assurance. British Journal of Clinical Pharmacology. 85(10). 2369–2377. 15 indexed citations
13.
14.
Lang, Benjamin, et al.. (2018). A comparison of group sequential and fixed sample size designs for bioequivalence trials with highly variable drugs. European Journal of Clinical Pharmacology. 74(5). 549–559. 5 indexed citations
15.
Lang, Benjamin, Kristina M. Holton, Jianlin Gong, & Stuart K. Calderwood. (2017). A Workflow Guide to RNA-seq Analysis of Chaperone Function and Beyond. Methods in molecular biology. 1709. 233–252. 4 indexed citations
17.
Lang, Benjamin, et al.. (2016). The Helicobacter pylori cytotoxin CagA is essential for suppressing host heat shock protein expression. Cell Stress and Chaperones. 21(3). 523–533. 19 indexed citations
18.
Sabo, John P., Jens Kort, Manuel Haschke, et al.. (2014). Clinical Assessment of Potential Drug Interactions of Faldaprevir, a Hepatitis C Virus Protease Inhibitor, With Darunavir/Ritonavir, Efavirenz, and Tenofovir. Clinical Infectious Diseases. 59(10). 1420–1428. 5 indexed citations
19.
Glund, Stephan, Joachim Stangier, Michael Schmohl, et al.. (2013). Abstract 17765: A Specific Antidote for Dabigatran: Immediate, Complete and Sustained Reversal of Dabigatran Induced Anticoagulation in Healthy Male Volunteers. Circulation. 128. 41 indexed citations
20.
Lang, Benjamin, Linh T. Nguyen, Jessica Vieusseux, et al.. (2012). Heat stress induces epithelial plasticity and cell migration independent of heat shock factor 1. Cell Stress and Chaperones. 17(6). 765–778. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026